Biểu đồ giá cổ phiếu IMRN
IMRN Dự đoán giá cổ phiếu
Immuron Limited
$0.89
11.11%
$0.08
Khi đóng cửa: May 13, 16:00:00 GMT-4
$0.9
2.22%
$0.01
Phiên sau giờ: May 13, 20:00:00 GMT-4
Quay lại
Immuron Limited (IMRN) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$0.801
Giá mở cửa
$0.8701
Phạm vi ngày
$0.81 - $0.98
Phạm vi 52 tuần
$0.677 - $2.39
Khối lượng
96.6K
Khối lượng trung bình
25.5K
Tỷ suất cổ tức
--
EPS (TTM)
-0.54
Vốn hóa thị trường
$7.4M
Immuron Limited là gì?
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.
